Expert panel to review applications today for emergency use of COVID-19 Vaccine


Central Drugs Standard Control will hold a meeting on December 9, 2020 to look at the applications of various pharmaceutical companies asking for approval for there COVID-19 vaccination respectively. This step is taken after Biotech Bharat became the third company to apply for emergency use to its Covaxin. Earlier Pfizer and Serum Institute applied for the same approval from Drug Control of India. During the trial phase, Covaxin changed its dosage from 3 micro-grams to 6 micro-grams. This will help in India getting its own official vaccination against COVID-19.




This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More